.png)
.png)
Associate Chief, Infection Control Unit
Massachusetts General Hospital
Boston, MA, United States
Dr. Shenoy is an infectious diseases physician at Massachusetts General Hospital (MGH) where she is Medical Director of the Emerging Special Pathogens Treatment Center at MGH, one of ten federally-funded centers with expertise in preparedness and response for emerging pathogens. In this role, she has responsibility for development and implementation of a comprehensive infection prevention program for the MGH Biocontainment Unit, the Special Pathogens Unit, and the Special Pathogens Program. She is the Associate Chief of the MGH Infection Control Unit and an Associate Professor of Medicine at Harvard Medical School.
Dr. Shenoy’s research has evaluated the clinical, operational and economic impact of infection control strategies for multi-drug resistant pathogens and prevention of hospital acquired infections through clinical studies and mathematical modeling, use of electronic health records for surveillance, and applied machine-learning techniques to create risk prediction models for infectious diseases. Dr. Shenoy is the Principal Investigator on a CDC-funded National Infection Prevention Strengthening grant focused on healthcare personnel (HCP) and patient safety. She has taught and published on detection and prevention of nosocomial infections and interventions, evaluation and management of HCP exposure to infectious agents, as well as pre- and post-exposure prophylaxis of HCP. During the COVID-19 pandemic she has served as the principal subject matter expert on infection prevention and control at MGH and advised the Mass General Brigham response, a large integrated healthcare system in Massachusetts and New Hampshire with 16 member institutions and more than 87,000 employees.
Dr. Shenoy is a Fellow in both the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). She has served on the Guidelines Committee of SHEA and currently Vice-Chair of SHEA’s Public Policy and Government Affairs Committee and co-chair of the Sterilization and High-Level Disinfection guidelines committee. An active member of IDSA, she previously served on the IDSA Antimicrobial Resistance Committee.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Thursday, October 20, 2022
8:00 AM – 9:00 AM US ET
Thursday, October 20, 2022
8:00 AM – 8:30 AM US ET
Friday, October 21, 2022
12:15 PM – 12:45 PM US ET